SCHEMBL25967987

SCHEMBL25967987

FC(F)(F)c1ccccc1CN1CCN(C2CCCCC2)CC1

nearest known ligand 0.86

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 9/20 0.86
KDM4E B2RXH2 7/20 0.86
ATM Q13315 2/20 0.61
POLB P06746 1/20 0.59
NPSR1 Q6W5P4 2/20 0.58
CHRM1 P11229 4/20 0.55
KMT2A Q03164 2/20 0.55
CYP1A2 P05177 1/20 0.55
CYP2D6 P10635 1/20 0.55
SMN1; SMN2 Q16637 1/20 0.55
TP53 P04637 1/20 0.53
TDP1 Q9NUW8 2/20 0.52
RECQL P46063 2/20 0.52
GAA P10253 1/20 0.52
DRD4 P21917 1/20 0.52
DRD3 P35462 1/20 0.52
HSD11B1 P28845 1/20 0.52
MEN1 O00255 1/20 0.50
DRD2 P14416 1/20 0.50
TSHR P16473 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6769005 0.82 ALDH1A1 (0.72) ALDH1A1KDM4EATMPOLBNPSR1
SCHEMBL3704635 0.82 ALDH1A1 (0.64) ALDH1A1KDM4EATMPOLBNPSR1
SCHEMBL16226753 0.81 ALDH1A1 (0.66) ALDH1A1KDM4EATMPOLBKMT2A
Hydrochloric Acid SCHEMBL3716083 0.81 ALDH1A1 (0.63) ALDH1A1KDM4EATMPOLBNPSR1
Cyclopentanamine SCHEMBL5925376 0.81 KDM4E (0.59) ALDH1A1KDM4EATMPOLBNPSR1
Hydrochloric Acid SCHEMBL7405455 0.81 ALDH1A1 (0.70) ALDH1A1KDM4EATMPOLBNPSR1
SCHEMBL31669175 0.80 ALDH1A1 (0.74) ALDH1A1KDM4EATMPOLBNPSR1
Hydrochloric Acid SCHEMBL3716147 0.80 CHRM1 (0.60) ALDH1A1KDM4EATMPOLBNPSR1
SCHEMBL3706431 0.79 GLA (0.62) ALDH1A1KDM4EATMPOLBCHRM1
SCHEMBL3705468 0.79 KDM4E (0.57) ALDH1A1KDM4EATMCHRM1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230257350-A1 COMPOUNDS AND METHODS OF PROMOTING OLIGODENDROCYTE PRECURSOR DIFFERENTIATION THE CLEVELAND CLINIC FOUNDATION 2023-08-17 US disclosed
US-20230257350-A1 COMPOUNDS AND METHODS OF PROMOTING OLIGODENDROCYTE PRECURSOR DIFFERENTIATION THE CLEVELAND CLINIC FOUNDATION 2023-08-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230257350-A1 COMPOUNDS AND METHODS OF PROMOTING OLIGODENDROCYTE PRECURSOR DIFFERENTIATION CHAT, DCX, GAP43 ALDH1A1 611/4885KDM4E 3073/4885ATM 3874/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.